Both in vivo and in vitro experiments have verified that TP53INP2 inhibits ccRCC cells by regulating caspase-8 apoptotic signaling pathway, so as to provide theoretical basis for further understanding of TP53INP2 and drug therapy of ccRCC. The gene discussed is TP53INP2; the disease is nonpapillary renal cell carcinoma.